Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery
Diabetes Technology & Therapeutics · 2025
DOI: 10.1089/dia.2024.0568 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes Technology & Therapeutics, 2025. Verfasst von Matilda M E Johansson und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Diabetic Retinopathy, Insulin, Hypoglycemic Agents. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Objective
Rapid improvements in glucose control may lead to early worsening of diabetic retinopathy (EWDR). There is a need to demonstrate safety in people commencing automated insulin delivery (AID) due to the known efficacy in rapid glycemic improvement. We aimed to investigate short-term DR outcomes in people (aged ≥13 years) with type 1 diabetes after initiation of AID (use ≥6 months). Research Design and Methods: Retrospective four center observational study with participants drawn from hospital databases (Dunedin and Christchurch, New Zealand) and also from two research studies based out of Auckland, New Zealand, and Perth, Australia. Demographic and clinical characteristics and DR grading data before and after AID initiation were collected, and statistical analysis was performed.
Results
DR grading data from 165 people using AID (three different AID systems) were available, and mean improvement in HbA1c for the total sample was 1.0 ± 1.3 percentage points. Improvements in grading were seen in 32/165 (19%), 99/165 (60%) were stable, and 34/165 (21%) worsened in their R- and/or M-grade. Age at AID initiation ≥18 years was the only significant risk factor for any worsening of DR ( P = 0.028). Proliferative change and need for photocoagulation were uncommon but did occur in 3% (5/165); all noted to have prior DR, diabetes duration >10 years, and with at least another diabetes complication or prior DR treatment.
Conclusions
In this study, stable or improved DR grades were evident in most who had recently commenced AID. Age at AID initiation
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Women's and Children's Health, University of Otago, Dunedin, New Zealand.
- Division of Pediatrics, Faculty of Health Sciences, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
- Ophthalmology, Department of Medicine, University of Otago, Dunedin, New Zealand.
- Paediatric Endocrinology, Starship Children's Health, Auckland, New Zealand.
- Department of Pediatrics and Child Health, University of Otago Wellington, Wellington, New Zealand.
- Children's Diabetes Centre, The Kids Research Institute and Perth Children's Hospital, Perth, Australia.
ORCID-Profile: Matilda M E Johansson, Craig A Jefferies, Mary B Abraham, Benjamin J Wheeler
Zitieren
APA
Johansson, M. M. E., March de Ribot, F., Sime, M. J., Boucsein, A., Zhou, Y., Jefferies, C. A., Paul, R. G., Wiltshire, E. J., Abraham, M. B., Jones, T. W., de Bock, M. I., & Wheeler, B. J. (2025). Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0568
Vancouver
Johansson MME, March de Ribot F, Sime MJ, Boucsein A, Zhou Y, Jefferies CA, et al. Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery. Diabetes Technology & Therapeutics. 2025. doi:10.1089/dia.2024.0568
BibTeX
@article{Johansson2025,
author = {Johansson, Matilda M E and March de Ribot, Francesc and Sime, Mary-Jane and Boucsein, Alisa and Zhou, Yongwen and Jefferies, Craig A and Paul, Ryan G and Wiltshire, Esko J and Abraham, Mary B and Jones, Timothy W and de Bock, Martin I and Wheeler, Benjamin J},
title = {Short-Term Diabetic Retinopathy Status in People with Type 1 Diabetes Commencing Automated Insulin Delivery},
journal = {Diabetes Technology & Therapeutics},
year = {2025},
doi = {10.1089/dia.2024.0568}
}
EUVIMED